Skip to main content
. 2022 Apr 2;32(11):7494–7503. doi: 10.1007/s00330-022-08766-8

Table 1.

VI-RADS score distribution by rater for each subset. VI-RADS, Vesical Imaging-Reporting and Data System

Subset 1 Subset 2 Subset 3 Subset 4 Subset 5 Total
N = 50 N = 50 N = 50 N = 50 N = 50 N = 250
Reference standard
No lesion 1 (2.0%) 3 (6.0%) 6 (12.0%) 3 (6.0%) 1 (2.0%) 14 (5.6%)
VI-RADS 1 4 (8.0%) 3 (6.0%) 4 (8.0%) 2 (4.0%) 4 (8.0%) 17 (6.8%)
VI-RADS 2 25 (50.0%) 27 (54.0%) 20 (40.0%) 29 (58.0%) 25 (50.0%) 126 (50.4%)
VI-RADS 3 2 (4.0%) 5 (10.0%) 2 (4.0%) 4 (8.0%) 2 (4.0%) 15 (6.0%)
VI-RADS 4 9 (18.0%) 4 (8.0%) 8 (16.0%) 4 (8.0%) 9 (18.0%) 34 (13.6%)
VI-RADS 5 9 (18.0%) 8 (16.0%) 10 (20.0%) 8 (16.0%) 9 (18.0%) 44 (17.6%)
Reader 1
No lesion 4 (8.0%) 4 (8.0%) 8 (16.0%) 3 (6.0%) 3 (6.0%) 22 (8.8%)
VI-RADS 1 4 (8.0%) 3 (6.0%) 6 (12.0%) 2 (4.0%) 3 (6.0%) 18 (7.2%)
VI-RADS 2 20 (40.0%) 29 (58.0%) 17 (34.0%) 30 (60.0%) 26 (52.0%) 122 (48.8%)
VI-RADS 3 2 (4.0%) 3 (6.0%) 3 (6.0%) 6 (12.0%) 2 (4.0%) 16 (6.4%)
VI-RADS 4 13 (26.0%) 1 (2.0%) 8 (16.0%) 3 (6.0%) 7 (14.0%) 32 (12.8%)
VI-RADS 5 7 (14.0%) 10 (20.0%) 8 (16.0%) 6 (12.0%) 9 (18.0%) 40 (16.0%)
Reader 2
No lesion 1 (2.0%) 4 (8.0%) 8 (16.0%) 4 (8.0%) 1 (2.0%) 18 (7.2%)
VI-RADS 1 5 (10.0%) 4 (8.0%) 5 (10.0%) 2 (4.0%) 3 (6.0%) 19 (7.6%)
VI-RADS 2 23 (46.0%) 28 (56.0%) 16 (32.0%) 28 (56.0%) 27 (54.0%) 122 (48.8%)
VI-RADS 3 9 (18.0%) 2 (4.0%) 6 (12.0%) 3 (6.0%) 3 (6.0%) 23 (9.2%)
VI-RADS 4 4 (8.0%) 3 (6.0%) 5 (10.0%) 2 (4.0%) 9 (18.0%) 23 (9.2%)
VI-RADS 5 8 (16.0%) 9 (18.0%) 10 (20.0%) 11 (22.0%) 7 (14.0%) 45 (18.0%)
Reader 3
No lesion 5 (10.0%) 3 (6.0%) 8 (16.0%) 3 (6.0%) 1 (2.0%) 20 (8.0%)
VI-RADS 1 1 (2.0%) 4 (8.0%) 4 (8.0%) 2 (4.0%) 3 (6.0%) 14 (5.6%)
VI-RADS 2 20 (40.0%) 25 (50.0%) 18 (36.0%) 30 (60.0%) 26 (52.0%) 119 (47.6%)
VI-RADS 3 8 (16.0%) 6 (12.0%) 4 (8.0%) 3 (6.0%) 6 (12.0%) 27 (10.8%)
VI-RADS 4 4 (8.0%) 3 (6.0%) 6 (12.0%) 3 (6.0%) 6 (12.0%) 22 (8.8%)
VI-RADS 5 12 (24.0%) 9 (18.0%) 10 (20.0%) 9 (18.0%) 8 (16.0%) 48 (19.2%)